Shares Of AI Company Surging On FDA 510(k) Clearance News

2025-02-27 12:55:00 ET

On a mixed trading day in the broader markets, there were some glimmers of strong bullishness coming from specific companies.

One such company was Ventripoint Diagnostics Ltd., (TSX-Venture:VPT) (OTC:VPTDF) , an industry leader in the application of AI (Artificial Intelligence) to echocardiography. Shares of Ventripoint are surging on the news that the company had received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for their VMS+™ 4.0 Automated Radiological Image Processing Software/System.

The VMS+ 4.0 system connects to standard echocardiography machines, the most widely used cardiac imaging technology globally. The system uses Ventripoint’s proprietary Knowledge Based Reconstruction technology to create 3D images of the heart and calculates volumes and ejection fraction for all 4 cardiac chambers with accuracy equivalent to MRI. The system can reduce the need for MRI in children and adults.

“Ventripoint has deep experience in the application of AI to echocardiography and this FDA clearance is the culmination of more than two years of research and development,” said Ventripoint President and CEO, Hugh MacNaught. “We are thrilled with the opportunity to offer U.S. hospitals an efficient and effective, non-invasive heart-imaging tools available.  AI enhanced echocardiograms are a fast, affordable and accessible tool for diagnosis and monitoring of the growing numbers of cardiac patients in America and worldwide.”

VMS+ 4.0 has already received regulatory clearance in other key markets such as the E.U., U.K. and Canada making this latest version of VMS+ available to the global community. Earlier versions of Ventripoint’s scanning technology received FDA, Health Canada and E.U. regulatory approvals and are being used by leading hospitals in the U.S., E.U., U.K. and Canada.

As mentioned, shares of VPT were currently trading up 58.82% while U.S. listed shares rallied 54.27% to $0.0975 in early-afternoon trading.

Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

View more of this article on AllPennyStocks.com.

About AllPennyStocks.com Media, Inc.:

Founded in 1999, AllPennyStocks.com is oneof North America’s leading platforms for micro-cap insights.

Catering to both Canadian and U.S. markets, we provide a wealth of resources and expert content designed for everyone—from beginner investors to seasoned traders.

AllPennyStocks.com is rapidly gaining recognition as a leading authority in the micro-cap space, with our insightful content prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals.

Want to showcase your company's story to a powerful network of investors? We can help you elevate your message and make a lasting impact. Contact us today.

Contact:

AllPennyStocks.com Media, Inc.

Email: ads@allpennystocks.com

Phone: (800) 558-4560 Ext: 101